News

Article

Boehringer Ingelheim Adopts Virtuosi VR Education Platform

Boehringer Ingelheim will use Virtuosi to train employees at three aseptic sites across its network.

Quality Executive Partners (QxP), global management consulting and educational technology firm, announced on Sept. 20, 2022 that Boehringer Ingelheim has officially deployed its Virtuosi VR education platform for employee training. Boehringer Ingelheim is set to deploy the technology at three aseptic sites across its network.

Virtuosi is a cloud-based learning platform that incorporates 56 courses and 26 VR immersive experiences in more than 100 hours of educational content. According to a company press, its modules are self-paced and fully learning management software-integrated for reporting and evaluation. Additionally, learners receive real-time coaching via responsive formative evaluation, coaching, and haptic feedback.

"QxP is proud to partner with Boehringer Ingelheim, a leading research-driven biopharmaceutical company. Virtuosi is helping Boehringer Ingelheim to further advance the skills and knowledge necessary in sterile manufacturing using tech-forward innovation," said Crystal Mersh, CEO, QxP, in the release.

Source: Quality Executive Partners

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content